HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.

7th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2026 | Boston, Massachusetts, USA

GAB 2026

Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2026 - Elizabeth Dale Gilley
The Elle Foundation, United States
Title : Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity

Abstract:

Introduction: This Editorial provides an update to the Elle Foundation Research Institute 100’s Family Genomic Series, including Case Studies 101-104 and 106. Our proband in Case Study 101 is in year 6 of a 10-year longitudinal Reward Deficiency Syndrome Solution case study. This case report provides an update for years 4, 5 and 6. Genomic era applications provided insight for neurological stability referred to as dopamine homeostasis to a multi-generational family with a variety of Reward Deficiency Syndrome symptomology and DSM-5 Mental Health Disorder clusters [1-3]. Review of the Elle Foundation Research 100s series in family genomics is an easy way to introduce the Reward Deficiency Syndrome Paradigm [4-5], to those who received their practitioner training in the traditional era, before the Human Genome Project [6] and WorldWide Gene Association studies [7-10] changed global perspective on precision addiction medicine [11].

Method: Reward Deficiency Syndrome (RDS) Solutions (RDSS) [12-13] were administered, including but not limited to: 1) the Genetic Addiction Risk Severity or GARS test [14-17]; 2) neurological analysis of genetic predisposition to inform the creation of personalized nutraceutical amino acid therapy (NAAT) [18] and pharmacogenomic interventions [19-20]; 3) a RDSS treatment plan [21] which considers individual genome, personality traits [22], intelligence (IQ) and mental health disorder clusters diagnosed by DMS 5 criteria [23]; 4) RDS Solution Focused Brief Intervention therapy [24], which includes an introduction to the RDS paradigm assisting patients in a reorientation of understanding of their mental health disorder challenges; and 5) new psychological tools for assessment of the severity of their symptoms (RDS-SOS) and development of improved self-management skill to achieve dopamine homeostasis [25].

Results: The proband created a foundation for recovery and flourishing [26] through her dedication to daily practice of Reward Deficiency Syndrome Solutions, treatment plan compliance, daily charting of severity of symptoms, and adherence to Precision Addiction Management (PAM) [27] revealing greater recovery resolve [28]. We found increased self-management skills which allowed her to self-monitor, taking necessary steps to regain dopamine homeostasis and maintain it [29]. Awareness Integration Therapy [30-31] was extremely helpful in reducing distress from Post-Traumatic Stress Disorder with Dissociative Multiplicity [32].

Biography:

Elizabeth Dale Gilley is a research scientist who focuses upon underlying neurogenetic and neurobiological syndrome which manifest as Substance Use Disorders and comorbid Mental Health Disorder Clusters.  The Elle Foundation 100 series in family genomics clearly demonstrates the Reward Deficiency Syndrome paradigm and how genomic applications  benefit RDS families over the generations. She is in her 6th year of longitudinal studies for the 100s series.  She is in the data collection analysis phase of the 200s series, which will inform the design of a much larger study known as the EF300s.  

Watsapp